Delayed local reactions after the first administration of the ChAdOx1 nCoV-19 vaccine.
作者信息
Shin Eunyong, Bae Seongman, Jung Jiwon, Song Woo-Jung, Kwon Hyouk-Soo, Kim Hee-Sung, Kim Sung-Han, Kim Tae-Bum, Cho You Sook, Lee Ji-Hyang
机构信息
Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
出版信息
Allergy. 2021 Nov;76(11):3520-3522. doi: 10.1111/all.14978. Epub 2021 Jun 26.
Abstract
摘要
相似文献
1
Delayed local reactions after the first administration of the ChAdOx1 nCoV-19 vaccine.首次接种ChAdOx1 nCoV-19疫苗后的局部延迟反应。
Allergy. 2021 Nov;76(11):3520-3522. doi: 10.1111/all.14978. Epub 2021 Jun 26.
2
Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports.腺病毒载体 ChAdOx1 nCoV-19 疫苗接种后引发浅静脉血栓形成：两例病例报告
J Med Case Rep. 2022 May 7;16(1):182. doi: 10.1186/s13256-022-03407-6.
3
Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an 'AstraZeneca arm'?ChAdOx1 nCoV-19疫苗的迟发性皮肤反应：它是“阿斯利康臂”吗？
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e711-e714. doi: 10.1111/jdv.17476. Epub 2021 Jul 12.
4
COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19.COVID-19 疫苗在免疫原性和炎症反应方面的类型依赖性差异：BNT162b2 和 ChAdOx1 nCoV-19。
Front Immunol. 2022 Sep 2;13:975363. doi: 10.3389/fimmu.2022.975363. eCollection 2022.
5
A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.腺病毒载体新冠疫苗（ChAdOx1 nCoV-19）接种后发生急性脱髓鞘性多发神经根神经病伴双侧面瘫 1 例。
Neurol Sci. 2021 Nov;42(11):4747-4749. doi: 10.1007/s10072-021-05467-w. Epub 2021 Jul 17.
6
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.COVID-19 疫苗效力下降和加强针的有效性和副作用：来自 ZOE COVID 研究的一项前瞻性社区研究。
Lancet Infect Dis. 2022 Jul;22(7):1002-1010. doi: 10.1016/S1473-3099(22)00146-3. Epub 2022 Apr 8.
7
Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2.针对 SARS-CoV-2 的三种不同疫苗加强免疫后的抗体反应动力学。
Front Immunol. 2022 Jan 19;13:811020. doi: 10.3389/fimmu.2022.811020. eCollection 2022.
8
Balancing the reactogenicity of the ChAdOx1 nCov-19 vaccine against COVID-19 and the urgent need of a large immunization in healthcare workers.平衡ChAdOx1 nCov-19新冠疫苗的反应原性与医护人员大规模免疫的迫切需求。
Therapie. 2022 May-Jun;77(3):371-373. doi: 10.1016/j.therap.2021.07.004. Epub 2021 Jul 27.
9
Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV-19 corona virus vaccine (recombinant).白细胞碎裂性血管炎作为 ChAdOx1 nCoV-19 冠状病毒疫苗（重组）的皮肤表现。
Dermatol Ther. 2021 Nov;34(6):e15141. doi: 10.1111/dth.15141. Epub 2021 Oct 5.
10
Reactogenicity among health care workers following a BNT162b2 or mRNA-1273 second dose after priming with a ChAdOx1 nCOV-19 vaccine.在使用 ChAdOx1 nCOV-19 疫苗进行初级免疫后，BNT162b2 或 mRNA-1273 第二针后医护人员的不良反应率。
Clin Microbiol Infect. 2022 Jun;28(6):885.e1-885.e5. doi: 10.1016/j.cmi.2022.02.010. Epub 2022 Feb 16.
引用本文的文献
1
Covishield™ (ChAdOx1 nCoV-19) Vaccine-Induced Systemic Drug-Related Intertriginous and Flexural Exanthema in a Young Girl: A Case Report and Literature Review.Covishield™（ChAdOx1 nCoV-19）疫苗诱发一名年轻女孩出现全身性药物相关擦烂性和屈侧疹：病例报告及文献综述
Indian J Dermatol. 2022 Nov-Dec;67(6):783-785. doi: 10.4103/ijd.ijd_511_22.
2
Cutaneous Complications of mRNA and AZD1222 COVID-19 Vaccines: A Worldwide Review.mRNA疫苗和AZD1222新冠疫苗的皮肤并发症：一项全球综述
Microorganisms. 2022 Mar 15;10(3):624. doi: 10.3390/microorganisms10030624.
本文引用的文献
1
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.对SARS-CoV-2的mRNA-1273疫苗的迟发性局部大反应
N Engl J Med. 2021 Apr 1;384(13):1273-1277. doi: 10.1056/NEJMc2102131. Epub 2021 Mar 3.
2
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.2020年12月14日至2021年1月18日美国接种mRNA新冠疫苗后发生过敏反应的报告
JAMA. 2021 Mar 16;325(11):1101-1102. doi: 10.1001/jama.2021.1967.
3
Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine.接种辉瑞-生物科技公司新冠mRNA疫苗后出现麻疹样皮疹。
Dermatol Online J. 2021 Jan 15;27(1):13030/qt4xs486zg.
4
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
5
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
6
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.在年轻和老年成年人中进行的一次单盲、随机、对照、2/3 期试验中，观察 ChAdOx1 nCoV-19 疫苗在初免-加强免疫方案中的安全性和免疫原性（COV002）。
Lancet. 2021 Dec 19;396(10267):1979-1993. doi: 10.1016/S0140-6736(20)32466-1. Epub 2020 Nov 19.
7
Immune-mediated adverse reactions to vaccines.疫苗免疫介导的不良反应。
Br J Clin Pharmacol. 2019 Dec;85(12):2694-2706. doi: 10.1111/bcp.14112. Epub 2019 Nov 5.
Zotero 插件